DyonMed, in collaboration with the Healthcare Professional and Scientific Medical Associations, is developing a new level of immediate and reliable prevention and Screening programs of general population. The programs are being implemented in the private practice in the workplace, or in special population groups following the relevant international medical protocols.
Areas for develop screening & prevention programs:
Microbleeding testing (fecal speciments) for early diagnosis and prevention of colon cancer
Immune control of the general population through immune antibodies to SARS CoV-2 Coron.
Upper gastrointestinal cancer prevention program through H. pylori
Upper gastrointestinal cancer prevention program through H. pylori
Screening of special population of children through testing of antibodies against transglutaminase for early diagnosis of celiac disease.
Prostate cancer prevention programs through PSA level measurement in population groups eg men over 40.
Renal control of patients, as prevention of nephrotic syndrome in a special group of patients with diabetes or even under statin medication through control of microalbumin.
Control of lipid profile or measurement of glycosylated Hemoglobin.

The goal & benefits:
• Early diagnosis and treatment of the disease
• Maximizing the therapeutic and economic output of National Health System
• Implementation of international prevention protocols or screening protocols of general population increasing Health services and prevention
Products for Prevention and Screening of general population (Point of Care testing)